John Wiley and Sons Class B shares show strong near-term price momentum with volume surging 2.7 times average, but the stock is near its 52-week high with no remaining upside to resistance and heavy research segment concentration, making the risk-reward unfavorable for new buyers.
Thesis pillars
- Strong Momentum Volume Surge→Stable
- Upside Exhaustion Near High→Stable
- Research Segment Concentration→Stable
- +1 more pillar — see the Why tab for full reasoning
John Wiley & Sons, Inc. (WLYB) Stock Analysis
Communication Services · Publishing
Hold if already holding. Not a fresh buy at $52.58, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Supplier: Cengage Learning.
John Wiley & Sons is a global publisher and research/learning company operating through two main segments -- Research (64% of fiscal 2025 consolidated revenue, including over 1,800 scholarly journals) and Learning (35%, spanning academic and professional publishing, courseware,... Read more
Hold if already holding. Not a fresh buy at $52.58, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Supplier: Cengage Learning. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.5/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
About John Wiley & Sons, Inc.
About John Wiley & Sons, Inc.
Wiley publishes more than 1,800 scholarly research journals and generated 64% of its fiscal 2025 consolidated revenue from its Research segment versus 35% from Learning (academic, professional publishing, courseware, and assessments). The company derived 83% of Adjusted Revenue from digital products and 48% on a recurring basis, with approximately 49% of consolidated revenue coming from outside the United States.
Research earns most of its revenue from multi-year Journal Subscriptions and Transformational Agreements with research libraries and consortia, supplemented by Open Access pay-to-publish fees and licensing revenue that increasingly includes licensing Wiley's content for AI model training. A substantial share of that content is not wholly owned by Wiley: approximately 46% of Journal Subscriptions revenue is derived from publication rights owned by professional societies and other publishing partners such as the American Cancer Society and the American Heart Association, published under long-term contracts that typically pay the society a royalty. Learning sells textbooks, courseware such as WileyPLUS and zyBooks, and assessment products like Everything DiSC through bookstores, online retailers, wholesalers, and direct sales, and does not own any printing facilities, instead contracting independent printers globally; the company has also outsourced its US-based book distribution operations to Cengage Learning to move toward a more variable cost structure.
Show full overview
A distinct angle beyond content-rights partnerships is physical distribution concentration: Wiley reports just one global warehousing and distribution facility, located in the UK, and has separately outsourced its entire US-based book distribution operation to a single partner, Cengage Learning. Because Learning still generates 35% of consolidated revenue and a meaningful share of that business depends on physical textbooks reaching bookstores and college stores on a seasonal cycle concentrated in the July-through-October and December-through-February periods, a disruption at either the UK facility or the Cengage distribution arrangement could delay textbook availability during Wiley's two most important selling windows, independent of demand for its digital Research content.
See also: Communication Services · Publishing
From John Wiley & Sons, Inc.'s most recent 10-K filing, extracted July 5, 2026.
Recent developments
updated 2026-07-06Recent Developments — John Wiley & Sons, Inc.
Latest news
- NEWS John Wiley & Sons Q4 2026 Earnings Call Transcript — benzinga Jun 17, 2026 neutral
- NEWS John Wiley & Sons Sees FY2027 Adj EPS $4.60-$5.05 vs $4.75 Est — benzinga Jun 16, 2026 neutral
- NEWS John Wiley & Sons Q4 Adj. EPS $1.67 Beats $1.65 Estimate, Sales $447.941M Miss $450.000M Estimate. — benzinga Jun 16, 2026 neutral
- NEWS Earnings Scheduled For June 16, 2026 — benzinga Jun 16, 2026 neutral
Generated 2026-07-06T06:00:35Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHProductResearch segment64%10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMGeographicoutside the US49%10-K Item 1: 'approximately 49% of our consolidated revenue was from outside the US'
- MEDIUMProductLearning segment35%10-K Item 1: 'Learning accounted for approximately 35% of our consolidated revenue in the year ended April 30, 2025'
- MEDIUMcounterpartyprofessional societies and publishing partners46%10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners'
- HIGHSupplierCengage Learning10-K Item 1: 'We have an agreement to outsource our US-based book distribution operations to Cengage Learning'
Material Events(8-K, last 90d)
- 2026-05-06Item 5.02MEDIUMEVP & GM Research and Learning Jay Flynn departed without cause effective May 11, 2026, eligible for severance under his Employment Letter and Executive Severance Policy. Jessica Kowalski (ex-Microsoft, AWS, RELX) appointed EVP & GM Research, also effective May 11, 2026.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $52.58, but acceptable to hold if already in. Reasons: Concentration risk — Product: Research segment (64.0%); Concentration risk — Supplier: Cengage Learning. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $60.47 (+15.0%), stop $50.72 (−3.7%), A.R:R 0.0:1. Score 6.5/10, moderate confidence.
Take-profit target: $60.47 (+15.0% upside). Target $60.47 (+15.0%), stop $50.72 (−3.7%), A.R:R 0.0:1. Stop-loss: $50.72.
Concentration risk — Product: Research segment (64.0%); Concentration risk — Supplier: Cengage Learning; Near 52-week high (0.0% away).
John Wiley & Sons, Inc. trades at a P/E of 12.6 (forward N/A). TrendMatrix value score: 9.2/10. Verdict: Hold.
5 analysts cover WLYB with a consensus score of 4.0/5.
What does John Wiley & Sons, Inc. do?John Wiley & Sons is a global publisher and research/learning company operating through two main segments -- Research...
John Wiley & Sons is a global publisher and research/learning company operating through two main segments -- Research (64% of fiscal 2025 consolidated revenue, including over 1,800 scholarly journals) and Learning (35%, spanning academic and professional publishing, courseware, and assessments). The company generated 83% of Adjusted Revenue digitally and 48% on a recurring basis in fiscal 2025, with approximately 49% of consolidated revenue coming from outside the US.